Frontotemporal dementia: Past, present, and future

Alzheimers Dement. 2023 Nov;19(11):5253-5263. doi: 10.1002/alz.13363. Epub 2023 Jun 28.

Abstract

Introduction: The history of frontotemporal dementia (FTD) is both old and new. This study explores its historical roots, dating back to the 19th century, while recognizes it as a distinct neurological entity only a few decades ago.

Methods: This qualitative study and literature review provides an overview of FTD's historical background, birth, evolution, and future directions.

Results: Recognition of FTD was hindered by rigid perceptions of dementia, the division between neurology and psychiatry, reliance on IQ-based assessment, limited neuroimaging capabilities, and lack of pathological proof. Overcoming these barriers involved revisiting early pioneers' approaches, focusing on focal impairment, establishing non-Alzheimer's disease cohorts, fostering collaboration, and developing diagnostic criteria. Current gaps include the need for biology-oriented psychiatry education, biological biomarkers, and culturally sensitive, objective clinical instruments predicting underlying pathology.

Discussion: Independent multidisciplinary centers are essential. The future of FTD lies in disease-modifying therapies, presenting new opportunities for healthcare professionals and researchers.

Keywords: behavioral sciences; dementia; dementia of the frontal type; frontal lobe dementia; frontotemporal dementia; history; neuropsychiatry; pick's disease and frontotemporal lobar degeneration.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Frontotemporal Dementia* / diagnosis
  • Humans
  • Neuroimaging
  • Neurology*
  • Pick Disease of the Brain* / history
  • Pick Disease of the Brain* / pathology

Substances

  • Biomarkers